List of Excipients in API darifenacin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing darifenacin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | HYPROMELLOSES | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | MAGNESIUM STEARATE | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | POLYETHYLENE GLYCOL 200 | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | TALC | |
| Allergan Inc | ENABLEX | darifenacin | 0430-0170 | TITANIUM DIOXIDE | |
| Actavis Pharma Inc | DARIFENACIN | darifenacin | 0591-4375 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing darifenacin
Detailed excipient profiles for darifenacin
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
darifenacin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
darifenacin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
darifenacin drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
darifenacin drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CELLULOSE, MICROCRYSTALLINE
darifenacin drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C YELLOW NO. 10
darifenacin drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing D&C YELLOW NO. 10
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
darifenacin drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: ETHYLCELLULOSE
darifenacin drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing ETHYLCELLULOSE
Excipient focus: FD&C YELLOW NO. 6
darifenacin drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
darifenacin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
darifenacin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYDROXYETHYL CELLULOSE
darifenacin drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
darifenacin drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
darifenacin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
darifenacin drug variants containing HYPROMELLOSE 2208
darifenacin drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
darifenacin drug variants containing HYPROMELLOSE 2910
darifenacin drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
darifenacin drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| Jubilant Cadista Pharmaceuticals Inc | darifenacin hydrobromide | 59746-516 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
darifenacin drug variants containing LACTOSE MONOHYDRATE
darifenacin drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
darifenacin drug variants containing MAGNESIUM STEARATE
darifenacin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
darifenacin drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing MALTODEXTRIN
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
darifenacin drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: POLYDEXTROSE
darifenacin drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Xiromed LLC | darifenacin hydrobromide | 70700-182 |
| Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
| Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
darifenacin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
| Physicians Total Care Inc | darifenacin | 54868-5704 |
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 1500
darifenacin drug variants containing POLYETHYLENE GLYCOL 1500
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 1500
Excipient focus: POLYETHYLENE GLYCOL 200
darifenacin drug variants containing POLYETHYLENE GLYCOL 200
| Company | Ingredient | NDC |
|---|---|---|
| Allergan Inc | darifenacin | 0430-0170 |
| Actavis Pharma Inc | darifenacin | 0591-4375 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 200
Excipient focus: POLYETHYLENE GLYCOL 400
darifenacin drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
| Bryant Ranch Prepack | darifenacin | 72162-2570 |
| Bryant Ranch Prepack | darifenacin | 72162-2571 |
| POLYGEN PHARMACEUTICALS INC | darifenacin hydrobromide | 52605-067 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
darifenacin drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | darifenacin hydrobromide | 69097-431 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
darifenacin drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
darifenacin drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Jubilant Cadista Pharmaceuticals Inc | darifenacin hydrobromide | 59746-516 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYVINYL ALCOHOL
darifenacin drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE K30
darifenacin drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | darifenacin | 16571-767 |
| Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
| Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
| Aurobindo Pharma Limited | darifenacin | 65862-861 |
| >Company | >Ingredient | >NDC |
darifenacin drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
darifenacin drug variants containing SILICON DIOXIDE
darifenacin drug variants not containing SILICON DIOXIDE
Excipient focus: TALC
darifenacin drug variants containing TALC
darifenacin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
darifenacin drug variants containing TITANIUM DIOXIDE
darifenacin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links